HDAC4 in ischemic stroke: mechanisms and therapeutic potential

Stroke is one of the leading causes of death and disability worldwide, and the majority of the cases are ischemic stroke. However, it still lacks effective treatment except for thrombolytic therapy in an extremely narrow time window. Increased evidence suggests that histone deacetylase 4 (HDAC4) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Qingsheng, Hao, Yongnan, Li, Xin, Wang, Xin, Ji, Bingyuan, Wu, Yili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136233/
https://www.ncbi.nlm.nih.gov/pubmed/30208931
http://dx.doi.org/10.1186/s13148-018-0549-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136233/
https://www.ncbi.nlm.nih.gov/pubmed/30208931
http://dx.doi.org/10.1186/s13148-018-0549-1

Ejemplares similares